Rising prevalence of infectious diseases, increasing investments in R&D activities, and growing application of antibiotics in development of bacterial and viral vaccines are key factors expected to drive market revenue growth.
Rising prevalence of infectious diseases, increasing investments in R&D activities, and growing application of antibiotics in development of bacterial and viral vaccines are key factors expected to drive market revenue growth
The global antibiotics market size is expected to reach USD 74.87 Billion in 2028 at a CAGR of 3.9% during the forecast period, according to latest report by Reports and Data. Increasing prevalence of infectious and bacterial diseases, rising investments to accelerate development of novel antibiotic therapies for infectious diseases, and growing number of R&D projects to discover and develop new antibiotics are key factors expected to drive market revenue growth over the forecast period. In addition, antibiotics are commonly used in the production of bacterial and viral vaccines to prevent contamination, which is another key factor expected to support revenue growth of the market.
Antibiotics are widely used in healthcare industry to treat and prevent bacterial and infectious diseases. Bactericidal antibiotics kill bacteria while bacteriostatic antibiotics prevent differentiation and growth of bacteria. Antibiotics are powerful drugs and drug-target interaction and effects of these drugs are well characterized. Over the recent past, various antibiotics are being used for therapeutic purposes and other industries such as animal husbandry and agriculture. Antibiotics are either cytotoxic or cytostatic to microorganisms and allows defense mechanism of the body to eliminate bacteria. These drugs act by inhibiting synthesis of a bacterial cell, synthesis or proteins, DNA, RNA, or other specific actions. Increasing demand for antibiotics across various sectors is leading to development and use of off-label drugs. Rising focus on modification of existing antibiotics to fight emerging resistance of pathogens is another major factor expected to boost revenue growth of the global antibiotics market.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1377
Antibiotics are widely available as over-the-counter drugs and can be bought without any prescription and this is another factor expected to fuel market revenue growth. These drugs have also been used in agricultural animal production as therapeutics to treat disease and prophylactically and to improve growth rate and feed conversion efficiency. Besides treating infectious diseases, antibiotics have made several medical procedures such as cancer treatment, organ transplant, and open heart surgery possible. However, increasing incidence of antibiotic resistance and high costs associated with clinical trials and drug approvals are some key factors that could hamper market revenue growth to a certain extent over the forecast period.
Some Key Highlights from the Report:
- Cell wall inhibitors segment is expected to account for largest revenue share over the forecast period attributable to increasing use of cell wall biosynthesis inhibiting antibiotics to treat drug resistant pathogens and rising focus on inhibition of cell wall synthesis for development of new antibiotics.
- Fluoroquinolones segment is expected to register robust revenue CAGR over the forecast period owing to recent advancements in fluoroquinolones to enhance antimicrobial and pharmacokinetic profiles, rising number of clinical trials to expand application scope of these antibiotics, and growing effectiveness of fluoroquinolones in vitro against gram positive pathogens.
- Oral segment is expected to account for significantly large revenue share over the forecast period attributable to increasing preference for oral antibiotic therapy, numerous advantages of oral administration over intravenous administration, and rising cost-effectiveness of oral administration.
- Hospital pharmacies segment is expected to register considerably high revenue growth rate over the forecast period owing to increasing availability of broad spectrum antibiotics in hospital pharmacies, rising hospital admissions due to bacterial and infectious diseases, and implementation of stringent policies to streamline antibiotic use in hospitals.
- North America is expected to account for largest revenue share between 2021 and 2028 owing to increasing prevalence of infectious diseases, growing investments to accelerate development of novel therapeutics, growing number of clinical trials, and presence of various key players in countries in the region.
- Major companies profiled in the market report include Bristol-Myers Squibb Co., AstraZeneca plc, The Menarini Group, GlaxoSmithKline plc, Bayer HealthCare AG, Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson, Novartis AG, Teva Pharmaceutical Industries Ltd., and Sanofi.
Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/antibiotics-market
For the purpose of this report, Reports and Data has segmented the global antibiotics market based on type, product outlook, administration mode, end use, and region:
Type Outlook (Revenue, USD Billion; 2018-2028)
- Protein
- DNA
- RNA
- Cell Wall Synthesis Inhibitors
- Mycolic Acid Inhibitors
Product Outlook (Revenue, USD Billion; 2018-2028)
- Carbapenems
- Penicillin
- Fluoroquinolones
- Macrolides
- Others
Administration Route Outlook (Revenue, USD Billion; 2018-2028)
- Oral
- Topical
- Sublingual
- Inhalation
- Others
End Use Outlook (Revenue, USD Billion; 2018-2028)
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Download Summary @ https://www.reportsanddata.com/download-summary-form/1377
Regional Outlook (Revenue, USD Billion, 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1377
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Radiation Proctitis Treatment Market Size, Share & Analysis, By Type (Non-Invasive, Invasive), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Therapy (Oral Therapy, Rectal Instillation Therapy, Thermal Therapy, Hyperbaric Oxygen Therapy), Route of Administration (Oral, Intravenous, Intramuscular) and Region, Forecast To 2028
Heart Attack Diagnostics Market By Test Type (Electrocardiogram, Blood Tests, Coronary Catheterization, Cardiac Computed Tomography, and Others), By Procedure (Invasive, Non-Invasive), By End-Use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others) and By Region, Forecast to 2028
Radiotherapy Market , By Type (External Beam Radiotherapy, Internal Beam Radiotherapy, and Systematic Radiotherapy), By Application (Breast Cancer, Head and Neck Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Skin and Lip Cancer, Cervical Cancer, and Others), By End Use, and By Region Forecast To 2028
HIV Diagnostics Market Size, Share, Trends, By Product (Consumables, Instruments, and Software & Services), By End-Use (Hospitals, Home Care Settings, Diagnostics Laboratories, Blood Banks, Others), By Test Type, and By Region Forecast to 2030
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-antibiotics-market